An official website of the United States government
) or https:// means you've safely connected to the .mil website. Share sensitive information only on official, secure websites.
Technologies Available for Licensing
VACCINE FOR TRANCUTANEOUS IMMUNIZATION
A vaccine delivered by transcutaneous immunization provides an effective treatment against infections by pathogens such as, for example, enterotoxigenic Escherichia coli (ETEC) and/or for symptoms of diarrheal disease caused thereby. For example, one, two, three, four, five or more antigens derived from ETEC and capable of inducing an antigen-specific immune response (e.g., toxins, colonization or virulence factors) and one or more optional adjuvant (e.g., whole bacterial ADP-ribosylating exotoxins, B subunits or toxoids thereof, detoxified mutants and derivatives thereof) are used to manufacture vaccines or to induce systemic and/or mucosal immunity.
Docket:WRAIR 99-63B
Publication/Issued No.:7,527,802
Publication/Issue Date:2009-05-05
Categories: Vaccine
More Detail:Visit USPTO.GOV
Lab:WRAIR
Inventor(s):GLENN, G.; CASSELS, F.